Study: Pyramax works as well as Coartem for malaria

Pyramax, an experimental once-a-day malaria drug developed by Korea's Shin Poong Pharmaceutical and the Medicines for Malaria Venture, works just as well as Novartis' twice-daily pill Coartem, according to a study published in the journal Lancet. The drug cleared the disease-causing parasite from the blood of 99.5 percent of patients in Africa and Asia after 28 days, compared with 99.2 percent for Coartem, said researchers led by Antoinette Tshefu at the University of...